These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Treatment of hemophilia with factor VIII concentrates. Agarwal MB; Mehta BC Indian J Med Sci; 1980 Sep; 34(9):226-30. PubMed ID: 6782019 [No Abstract] [Full Text] [Related]
4. Prophylactic treatment for prevention of joint disease in hemophilia--cost versus benefit. Roosendaal G; Lafeber F N Engl J Med; 2007 Aug; 357(6):603-5. PubMed ID: 17687136 [No Abstract] [Full Text] [Related]
5. Supply and need of factor VIII concentrates. Britten A; Etzel F; Ala F; Carman C; Smit Sibinga C Haematologia (Budap); 1983; 16(1-4):109-20. PubMed ID: 6434377 [TBL] [Abstract][Full Text] [Related]
6. Factor VIII usage in the Wisconsin Hemophilia Program; factor VIII usage in hemophilia. Lange D; Lazerson J Wis Med J; 1982 Feb; 81(2):28-31. PubMed ID: 6803446 [No Abstract] [Full Text] [Related]
7. [in vivo reappearance of injected cryoprecopitate (factor VIII concentrates) in patients with hemophilia A]. Kuble M; Wegner H; Cron D Z Gesamte Inn Med; 1973 Oct; 28(20):608-14. PubMed ID: 4767194 [No Abstract] [Full Text] [Related]
8. The clinical use of porcine factor VIII. Kernoff PB Prog Clin Biol Res; 1990; 324():47-56. PubMed ID: 2106692 [TBL] [Abstract][Full Text] [Related]
9. Treatment of hemophilia with factor 8 concentrates. Dallman PR; Pool JG N Engl J Med; 1968 Jan; 278(4):199-202. PubMed ID: 5711341 [No Abstract] [Full Text] [Related]
10. Continuous infusion of factor VIII concentrates in obese patients with severe haemophilia A: is weight-based dose-adjustment required? Boban A; Henrard S; Lambert C; Hermans C Haemophilia; 2016 Jan; 22(1):e62-4. PubMed ID: 26560746 [No Abstract] [Full Text] [Related]
12. Lower doses of factor VIII for hemophilia. Penner JA; Kelly PE N Engl J Med; 1977 Aug; 297(7):401. PubMed ID: 876340 [No Abstract] [Full Text] [Related]
13. [Preparation and use of factor VIII concentrates in hemophilia]. Vilar JM; Ortega F; Martin-Arias DM; Vazquez J; Navarro JL Sangre (Barc); 1969; 14(1):57-64. PubMed ID: 5792112 [No Abstract] [Full Text] [Related]
14. Financial aspects of hemophilia care. Carman CJ; Britten AF; Ala F; Smit Sibinga C Scand J Haematol Suppl; 1984; 40():529-33. PubMed ID: 6433476 [No Abstract] [Full Text] [Related]
15. Should hemophilia treaters switch to albumin-free recombinant factor VIII concentrates. Meeks SL; Josephson CD Curr Opin Hematol; 2006 Nov; 13(6):457-61. PubMed ID: 17053459 [TBL] [Abstract][Full Text] [Related]
16. [Changes in coagulation factor VIII after liver transplantation in a patient with hemophilia A]. Deshayes JP; Tartière J; Samba D; Auvray S; Segol P; Lequerrec A; Derlon A Presse Med; 1992 Feb; 21(5):216. PubMed ID: 1532088 [No Abstract] [Full Text] [Related]
17. Hemostasis. II. The use of factor VIII concentrates in the therapy of hemophilia. Davis RB Nebr State Med J; 1971 Jun; 56(6):219-24. PubMed ID: 4253029 [No Abstract] [Full Text] [Related]
18. Recombinant clotting factors in the treatment of hemophilia. Lee C Thromb Haemost; 1999 Aug; 82(2):516-24. PubMed ID: 10605745 [No Abstract] [Full Text] [Related]